Skip to main content
. 2013 Jun 30;29(3):100–105. doi: 10.3393/ac.2013.29.3.100

Fig. 1.

Fig. 1

The 2-year disease-free survival in stage III rectal cancer was significantly better in the lymph node ratio (LNR) <15% group than it was in the LNR ≥ 15% group (95.2% and 67.6%, respectively, P = 0.02).